Verilogue to Present on Patient-Physician Vaccine Discussions at 2009 International Conference on Communication in Healthcare
* Reuters is not responsible for the content in this press release.
http://www.businesswire.com/news/home/20091005005004/en
Director of Linguistic Insights and Analytics to Deliver Analysis on Physician
Strategies, Roles & Ethics When Recommending Gardasil Vaccine
--(Business Wire)--
Verilogue:
WHO: David Franke, Verilogue Director of Linguistic Insights and Analytics
WHAT: Franke will deliver a presentation entitled "Patient Autonomy, Clinical Objectivity and the Ethics of Physician Persuasion in Vaccine Discussions."
Recently, patients and caregivers have become wary of vaccine safety and physicians` motives in making recommendations to vaccinate. Franke`s presentation will offer
insights into the communicative challenge and ethical dilemma for physicians when recommending vaccines to patients, referencing data from Verilogue`s study on physicians
who recommended the Gardasil vaccine. The study demonstrates how physicians use a wide range of strategies to deliver information about Gardasil and addresses the broader
question around how physicians balance their roles as objective treatment providers and subjective persuaders.
WHEN: Monday, October 5, 2009, 1:30-3:00 p.m. ET
WHERE: International Conference on Communication in Healthcare to be held October 4-7, 2009 in Miami. This year`s conference will emphasize ethical issues in healthcare
communication, patient safety as a communication issue and inter-cultural issues in communication. The conference is organized by the American Academy on Communication in
Healthcare (AACH) in partnership with the European Association for Communication in Healthcare (EACH).
About Verilogue
Verilogue (www.verilogue.com) is the first health care market research company
to uncover, analyze and deliver nationwide insights derived from
naturally-occurring dialogue between patients and physicians. With its
patent-pending Point-of-Practice database and technology system, which digitally
records real-time conversations between patients and physicians, Verilogue is
able to capture critical information at the point of care, while maintaining
patient and physician confidentiality. The insights gathered from these
conversations, analyzed by Verilogue`s team of linguists, statisticians and
marketing experts, enable pharmaceutical and health care companies to gain a
deeper understanding of patient and physician perspectives, help shape
conversations that affect health care decisions, identify the most effective
methods and tools to reach patients and drive the development and improvement of
new and existing treatments to ultimately improve patient care.
More than 25 pharmaceutical companies have partnered with Verilogue to gain
actionable insights from its database containing 30,000+ unique
physician-patient conversations and corresponding patient charts across 50+
therapeutic categories. Founded in 2006, Verilogue is a privately-held company
headquartered in Horsham, PA.
Lois Paul & Partners
Susan McCarron, 781-782-5767
susan_mccarron@lpp.com
Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters